IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q4 2025 Holdings

Filed 2026-02-17 | 9 holdings | $222.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Innoviva Inc(INVA)COM45781M101$56.3M2,816,02225.3%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$53.6M15,919,43524.1%
Neurocrine Biosciences Inc(NBIX)COM64125C109$43.0M303,15119.3%
Cytokinetics Inc(CYTK)COM NEW23282W605$25.2M396,35711.3%
Amarin Corp PLC(EH3)SPONSORED ADR023111404$23.4M1,673,39510.5%
Lantheus Hldgs Inc(LNTH)COM516544103$12.1M181,4505.4%
Biohaven LTD(BHVN)COMG1110E107$5.8M513,1842.6%
Regeneron Pharmaceuticals(REGN)COM75886F107$3.2M4,1901.5%
VOR Biopharma Inc(VOR)COM NEW929033207$332.2K25,3990.1%